ROCKWELL MEDICAL INC. RECEIVES FDA APPROVAL (NASDAQ: RMTI) – RICH TV LIVE – MARCH 27, 2020 – I OWN 1000 SHARES OF ROCKWELL MEDICAL – Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today announced that the U.S. Food and Drug Administration (“FDA”) has approved its New Drug Application (“NDA”) for its intravenous formulation of Triferic, Triferic AVNU. With this approval, Triferic AVNU joins Triferic Dialysate as the only FDA-approved products indicated to replace iron and maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease.
News and i told you guys i’ve been telling you all week i said rockville medicals is about to get fda approval and there it is and she goes rockwell medical inc receives fda approval for tri farik at avenue farik pro 5-8 citrate intravenous formulation of tri ferric for replacement of iron and maintenance of hemoglobin in hemodialysis patients this is brig news
Breaking news this just broke enhances try ferric platform for providing patients with inter access to rockwell medicals innovative therapeutics by expanding administration options for clinicians major milestone supports the potential for expanding global adoption of tri ferric and transforming the standard of care for anaemia management in hemodialysis patients
This is breaking news rockwell medical inc just got fda approval and they’re up and i am a shareholder and i’m a happy man right now i do own a thousand shares of rockwell medical told you guys medicinal stocks if the approval stocks can make you a killing rockwell medical moving on the big news they just got fda approval put them on your watch list put them on your
Radar m r m t i richard marry tom investment on the nasdaq r m t i hey voo how you doing who asks how much you think it will be up it’s up right now it’s up right now i mean it’s got price targets from analysts anywhere from six to eight dollars it’s currently around three i think and go away higher i’m a shareholder i’m not planning to sell unless it goes on a
Huge run for the rest of the day i don’t plan to sell but you know if it goes to five six seven eight dollars i will sell so yeah rmt i just got fda approval big news breaking news and i told you guys i always like to come first with the news so let me try to break you guys the news here rockwell medical inc a biopharmaceutical company dedicated transforming amenia
Management and improving outcomes for patients around the world today announced that the us food and drug administration the fda has approved its new drug application and dea for its intravenous formulation of try ferric tri ferric and av and you with disapproval try ferric avnu joins try ferric dialysate as the only fda approved products indicated to replace iron
And maintain hemoglobin in adult patients with hemodialysis dependent chronic kidney disease says huge news this is breaking news boo dang says i have a call on it so i hope a man i hope for you too brother i hope for you too but this they just got fda approval so you’d have to assume that this is going to start to circulate more and more institutions gonna hear
About this and they’re gonna want to jump on this because this is pretty huge news pretty massive news traffic is novel physiological iron maintenance therapy that provides bioavailable iron to replace iron loss during every dialysis treatment and maintain hemoglobin while try ferric dialysate is designed to be administered via liquid bio carbonate try ferric
Av and u is designed for direct intravenous infusion which provides hemodialysis patients with greater access to the tri ferric platform and expands administration options for clinicians try ferric av and new can be administered regardless of a dialysis centers mode of bicarbonate delivery many dialysis centers in international markets and an increasing number
Of dialysis centers in the us have converted to the use of dry bicarbonate cartridges or bags and online dialysate generation which is not compatible with tri ferric dialysate the approval of tri ferric av and u is a major milestone as we further progress towards our goal of transforming amenia management across the globe with tri ferric av and you more adult
Hemodialysis patients in the us will have access to the benefits of this the unique therapeutic regardless of the way their clinic generates bicarbonate clinicians will now have the added flexibility to administer tri ferric intravenously to a broader group of patients who can benefit from psychologic iron maintenance therapy to manage their amenia stated stuart
Paul president and chief executive officer of rockwell medical wow this is big news this is why i like to get into stocks before they get fda approval i love to get into stocks before they get into fda approval and stocks that are about to get fda approval or started to become stocks that i’m really interested in so i think as a community we need to really study
Companies that are going to get fda approval because typically after a stock gets fda approval rocket fuel so rockwell medical just got fda approval the approval of trife eric a v and u is a major milestone we further progress towards our goal of transforming amenia management across the globe that was stuart paul clinical trials have demonstrated that patients
Treated with trife eric received steady and consistent by available iron to replace the iron that is lost at every dialysis treatment and hemoglobin is maintained now even in clinics where deriving try ferric through the dial s8 is not operationally possible try ferric av and you is an option this miss may this may be especially important for patients who are
Difficult to manage or for other special patient populations added dr. stephen fish bein chief of nephrology of northwell health and professor of medicine at the zucker school of medicine over the next several months the company plans to initiate a commercial strategy the leverages the experience gained from the 2019 launch of tri ferric dialysate and lays the
Groundwork for the commercial introduction of tri ferric avnu the company expects to launch evaluation programs during the third quarter of 2020 to allow clinics to gain direct experience with tri ferric avnu and the company expects tri ferric avnu to be available commercially following the completion of the initial evaluation programs about rockwell medical
Rockwell medical is a biopharmaceutical company dedicated to transforming amenia management in a wide variety of therapeutic areas and across the globe improving the lives of brief sick patients the company’s initial focus is the treatment of amenia in end-stage and renal disease esrd rockwell’s medical exclusive renal drug therapy tri ferric fair pyrophosphate
Citrate is the only fda-approved therapeutic indicated for iron replacement and maintenance of hemoglobin in hemodialysis patients rockwell medical is also an established manufacturer supplier and leader in delivering high quality hemodialysis concentrates dial assets to dialysis providers and distributors in the us and abroad wow some big news guys this is the
Big news rockwell medical inc receives fda approval for try ferric i am a shareholder big news breaking news i oh i do own 1,000 shares of rockwell medical stay tuned if there’s any other big news or breaking news that happens today i will let you know first keep our m ti on your watch list keep it on your radar i’m shareholder they’re having a big day so far fda
Approval stay tuned penny yet if anything else happens that’s really big or trending you know i will break it first and in about 18 minutes i will be live-streaming the teleconference from the world health organization stay tuned is your boy rich or miss to be live and i’m out peace rmt i told you guys fda approval it’s true
Transcribed from video
ROCKWELL MEDICAL INC. RECEIVES FDA APPROVAL (NASDAQ: RMTI) By RICH TV LIVEliveBroadcastDetails{isLiveNowfalsestartTimestamp2020-03-27T152853+0000endTimestamp2020-03-27T153838+0000}
